US Stock MarketDetailed Quotes

Apogee Therapeutics (APGE)

Watchlist
  • 82.930
  • -1.670-1.97%
Close May 12 16:00 ET
  • 81.350
  • -1.580-1.91%
Post 17:21 ET
6.25BMarket Cap-19.15P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apogee Therapeutics (APGE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.63%-55.57M
-32.88%-227.45M
7.42%-62.69M
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
Net income from continuing operations
-33.92%-74.11M
-40.46%-255.84M
-3.23%-69.39M
-32.65%-65.02M
-95.46%-66.1M
-72.43%-55.34M
-116.88%-182.15M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
Depreciation and amortization
97.10%408K
650.26%1.42M
434.21%406K
745.83%406K
1,008.33%399K
613.79%207K
--189K
--76K
--48K
--36K
Other non cash items
14.35%980K
117.06%3.68M
26.02%959K
142.89%940K
228.93%921K
222.18%857K
1,847.13%1.69M
--761K
--387K
--280K
Change In working capital
152.46%1.55M
-673.13%-15.48M
18.49%-4.86M
-122.47%-837K
-543.39%-6.84M
-124.60%-2.95M
-132.79%-2M
-336.16%-5.96M
1,290.10%3.73M
-51.84%1.54M
-Change in prepaid assets
-378.21%-2.49M
65.36%-2.11M
375.50%1.64M
25.03%-2.11M
-109.15%-2.54M
161.22%895K
-118.31%-6.08M
-196.60%-596K
-95.34%-2.81M
36.82%-1.21M
-Change in payables and accrued expense
16.78%4.68M
-117.70%-924K
-9.85%-5.57M
-64.14%2.44M
-159.07%-1.81M
873.54%4.01M
-43.67%5.22M
-322.04%-5.07M
505.24%6.81M
-40.14%3.07M
-Change in other current assets
102.27%155K
-8,628.87%-8.47M
356.25%73K
-293.48%-181K
-2,165.67%-1.52M
---6.84M
9.35%-97K
114.95%16K
---46K
---67K
-Change in other current liabilities
20.91%-802K
-280.96%-3.98M
-224.92%-1M
-333.19%-992K
-297.95%-971K
-285.55%-1.01M
-287.04%-1.05M
-14.44%-309K
---229K
---244K
Cash from discontinued investing activities
Operating cash flow
-14.63%-55.57M
-32.88%-227.45M
7.42%-62.69M
-27.59%-54.26M
-111.70%-62.03M
-53.23%-48.48M
-128.96%-171.17M
-127.58%-67.71M
-113.90%-42.52M
-101.10%-29.3M
Investing cash flow
Cash flow from continuing investing activities
-372.29%-35.35M
40.23%-179.57M
-722.48%-288.63M
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
-148.71M
Net PPE purchase and sale
--0
-346.79%-5.15M
-6,300.00%-62K
--0
-1,405.88%-768K
-1,129.91%-4.32M
-589.82%-1.15M
100.60%1K
---751K
---51K
Net investment purchase and sale
-304.34%-35.35M
41.72%-174.43M
-722.36%-288.56M
112.32%17.95M
153.07%78.89M
133.66%17.3M
-9.34%-299.31M
217.31%46.37M
37.82%-145.63M
---148.66M
Cash from discontinued investing activities
Investing cash flow
-372.29%-35.35M
40.23%-179.57M
-722.48%-288.63M
112.26%17.95M
152.54%78.13M
125.09%12.98M
-9.69%-300.46M
216.82%46.37M
37.50%-146.38M
---148.71M
Financing cash flow
Cash flow from continuing financing activities
66,004.02%411.17M
-19.92%396.49M
745.32%374.95M
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
Net common stock issuance
--407.1M
-21.04%389.63M
750.61%370.25M
--19.38M
--0
--0
56.47%493.48M
20,535.68%43.53M
--0
---541K
Proceeds from stock option exercised by employees
553.38%4.06M
321.65%6.86M
467.39%4.7M
-7.05%356K
201.79%1.18M
2,491.67%622K
--1.63M
--828K
--383K
--391K
Cash from discontinued financing activities
Financing cash flow
66,004.02%411.17M
-19.92%396.49M
745.32%374.95M
5,053.52%19.74M
886.67%1.18M
-99.86%622K
56.98%495.11M
20,924.41%44.36M
-99.88%383K
91.15%-150K
Net cash flow
Beginning cash position
-7.41%131.55M
19.79%142.08M
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
-21.91%118.61M
-36.75%119.07M
145.94%307.59M
243.69%485.75M
Current changes in cash
1,018.33%320.25M
-144.88%-10.53M
2.72%23.64M
91.21%-16.57M
109.70%17.28M
-109.50%-34.87M
170.53%23.47M
133.03%23.01M
-398.29%-188.52M
-995.41%-178.16M
End cash Position
321.41%451.8M
-7.41%131.55M
-7.41%131.55M
-9.37%107.91M
-59.53%124.49M
-77.93%107.21M
19.79%142.08M
19.79%142.08M
-36.75%119.07M
145.94%307.59M
Free cash flow
-5.26%-55.57M
-34.97%-232.6M
7.33%-62.75M
-25.37%-54.26M
-113.95%-62.8M
-65.05%-52.79M
-129.99%-172.33M
-126.31%-67.71M
-117.68%-43.28M
-101.45%-29.35M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.63%-55.57M-32.88%-227.45M7.42%-62.69M-27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M
Net income from continuing operations -33.92%-74.11M-40.46%-255.84M-3.23%-69.39M-32.65%-65.02M-95.46%-66.1M-72.43%-55.34M-116.88%-182.15M-111.81%-67.22M-135.21%-49.02M-79.06%-33.82M
Depreciation and amortization 97.10%408K650.26%1.42M434.21%406K745.83%406K1,008.33%399K613.79%207K--189K--76K--48K--36K
Other non cash items 14.35%980K117.06%3.68M26.02%959K142.89%940K228.93%921K222.18%857K1,847.13%1.69M--761K--387K--280K
Change In working capital 152.46%1.55M-673.13%-15.48M18.49%-4.86M-122.47%-837K-543.39%-6.84M-124.60%-2.95M-132.79%-2M-336.16%-5.96M1,290.10%3.73M-51.84%1.54M
-Change in prepaid assets -378.21%-2.49M65.36%-2.11M375.50%1.64M25.03%-2.11M-109.15%-2.54M161.22%895K-118.31%-6.08M-196.60%-596K-95.34%-2.81M36.82%-1.21M
-Change in payables and accrued expense 16.78%4.68M-117.70%-924K-9.85%-5.57M-64.14%2.44M-159.07%-1.81M873.54%4.01M-43.67%5.22M-322.04%-5.07M505.24%6.81M-40.14%3.07M
-Change in other current assets 102.27%155K-8,628.87%-8.47M356.25%73K-293.48%-181K-2,165.67%-1.52M---6.84M9.35%-97K114.95%16K---46K---67K
-Change in other current liabilities 20.91%-802K-280.96%-3.98M-224.92%-1M-333.19%-992K-297.95%-971K-285.55%-1.01M-287.04%-1.05M-14.44%-309K---229K---244K
Cash from discontinued investing activities
Operating cash flow -14.63%-55.57M-32.88%-227.45M7.42%-62.69M-27.59%-54.26M-111.70%-62.03M-53.23%-48.48M-128.96%-171.17M-127.58%-67.71M-113.90%-42.52M-101.10%-29.3M
Investing cash flow
Cash flow from continuing investing activities -372.29%-35.35M40.23%-179.57M-722.48%-288.63M112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M-148.71M
Net PPE purchase and sale --0-346.79%-5.15M-6,300.00%-62K--0-1,405.88%-768K-1,129.91%-4.32M-589.82%-1.15M100.60%1K---751K---51K
Net investment purchase and sale -304.34%-35.35M41.72%-174.43M-722.36%-288.56M112.32%17.95M153.07%78.89M133.66%17.3M-9.34%-299.31M217.31%46.37M37.82%-145.63M---148.66M
Cash from discontinued investing activities
Investing cash flow -372.29%-35.35M40.23%-179.57M-722.48%-288.63M112.26%17.95M152.54%78.13M125.09%12.98M-9.69%-300.46M216.82%46.37M37.50%-146.38M---148.71M
Financing cash flow
Cash flow from continuing financing activities 66,004.02%411.17M-19.92%396.49M745.32%374.95M5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K
Net common stock issuance --407.1M-21.04%389.63M750.61%370.25M--19.38M--0--056.47%493.48M20,535.68%43.53M--0---541K
Proceeds from stock option exercised by employees 553.38%4.06M321.65%6.86M467.39%4.7M-7.05%356K201.79%1.18M2,491.67%622K--1.63M--828K--383K--391K
Cash from discontinued financing activities
Financing cash flow 66,004.02%411.17M-19.92%396.49M745.32%374.95M5,053.52%19.74M886.67%1.18M-99.86%622K56.98%495.11M20,924.41%44.36M-99.88%383K91.15%-150K
Net cash flow
Beginning cash position -7.41%131.55M19.79%142.08M-9.37%107.91M-59.53%124.49M-77.93%107.21M19.79%142.08M-21.91%118.61M-36.75%119.07M145.94%307.59M243.69%485.75M
Current changes in cash 1,018.33%320.25M-144.88%-10.53M2.72%23.64M91.21%-16.57M109.70%17.28M-109.50%-34.87M170.53%23.47M133.03%23.01M-398.29%-188.52M-995.41%-178.16M
End cash Position 321.41%451.8M-7.41%131.55M-7.41%131.55M-9.37%107.91M-59.53%124.49M-77.93%107.21M19.79%142.08M19.79%142.08M-36.75%119.07M145.94%307.59M
Free cash flow -5.26%-55.57M-34.97%-232.6M7.33%-62.75M-25.37%-54.26M-113.95%-62.8M-65.05%-52.79M-129.99%-172.33M-126.31%-67.71M-117.68%-43.28M-101.45%-29.35M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -